Tuesday, March 3, 2009

Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids

Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids

Female patients at the KK Women's and Children's Hospital (KKH) can now opt for a "non-contact" form of surgery that allows them to undergo an anesthetic-free yet almost painless operation to treat uterine fibroids.

Singapore (PRWEB) March 3, 2009 -- Female patients at the KK Women's and Children's Hospital (http://www.singaporemedicine.com/hcp/intl_pts_svcs_ctr.asp) (KKH) can now opt for a "non-contact" form of surgery that allows them to undergo an anesthetic-free yet almost painless operation to treat uterine fibroids (http://www.singaporemedicine.com/intl_pts_guide/preparation.asp).

Called MR-guided focused ultrasound ablation (http://www.singaporemedicine.com/leadingmedhub/leadingmedhub1.asp) (MRgFUS), the procedure involves no cuts, no down time and none of the usual risks associated with surgery. Rather, it makes use of heat generated from ultrasound to burn away fibroids, which are abnormal masses of muscular tissue.

"This procedure has two parts to it. The first step is to find out exactly where the abnormalities are in order to mark out the treatment areas. This will be done through Magnetic Resonance Imaging or MRI.

"The next step is to direct the ultrasound machine at these problematic spots and systematically destroy them," says Dr Ong Chiou Li, Senior Consultant Radiologist at KKH's Diagnostic Imaging Department.

At a temperature of 60 degrees Celsius, heat that is generated from ultrasound can kill off any undesirable cells in the body.

"Usually, our treatment temperature ranges from between 60 to 80 degrees Celsius. Only a small area of about 1cm width will be treated each time, for about 20 seconds. Once we clear one spot, we will turn the heat off and focus on the next area," explains Dr Ong.

The procedure is a painstaking one for the doctors, but a relative walk in the park for patients. All the latter has to do is lie flat on her stomach on the MRI platform and let the machines do the rest.

"The only important thing is that patients must remain still throughout, and that may be difficult for some because the entire process can take three to four hours, depending on the size of the fibroids," she adds.

Approved by the FDA in 2004, KKH was the first and only hospital in Southeast Asia (http://www.singaporemedicine.com/hcp/hcp1.asp) to acquire the necessary technology, at a cost of about US$1 million. To date, 33 patients have been treated successfully, with five requiring second treatments.

According to Dr Ong, women who qualify for treatment include those whose fibroids are less than 10cm in size. Conventionally, the removal of such fibroids will require either keyhole or open surgery, which will mean having to stay a spell in hospital.

Patients undergoing this procedure would only feel some heat and may experience slight cramps in the abdomen, but there is usually little or no pain.

"We will offer the patient a sedative, or pain killer if necessary, but anesthesia is not given so the patient will remain responsive at all times," says Dr Ong, who adds that the procedure is considered safe for young women as it has been shown not to interfere with future pregnancies.

Since the procedure involves no cuts, there is none of the usual risks associated with conventional surgical treatments, such as risk of infection, blood loss or blood poisoning.

And here's the really good news - the cost. A similar procedure in the United States will cost upwards of US$6,500. At KKH, charges are less than half that.

Fibroids (http://www.singaporemedicine.com/healthcaredest/sg.asp) are a relatively common affliction amongst women. Almost 20 percent of all women get fibroids.

"Most fibroids are benign and grow at the rate of about 1cm per year. It can interfere with menstrual flow, so we usually recommend treatment if it gets bigger than 5cm," explains Dr Ong. Causes are still unknown, although doctors have noted a genetic element in women with fibroids.

The treatment is good for women in their 30s to late 40s but is not recommended to women with menopause.

"There is no longer a need for treatment post-menopause because without hormonal stimulation, the fibroids will shrink on their own," says Dr Ong.

About KK Women's and Children's Hospital

KK Women's and Children's Hospital, or simply KKH, is the largest medical facility in Singapore which provides specialized care for women, babies and children. Since its inception in 1924, it has grown into a 830-bed tertiary hospital for women and children. Every year, KKH registers over 600,000 visits by women and children who come as inpatients or outpatients. In addition, one-third of all couples in Singapore choose to deliver their babies at KKH. (www.kkh.com.sg)

About SingaporeMedicine

Launched in 2003, SingaporeMedicine is a multi-agency government-industry partnership committed to strengthening Singapore's position as www.singaporemedicine.com Asia's leading medical hub and international health care destination (http://www.singaporemedicine.com/healthcaredest/healthcaredest1.asp). Led by the Ministry of Health of Singapore, SingaporeMedicine is supported by three government agencies: the Economic Development Board, which develops industry capabilities, the International Enterprise Singapore, which fosters regionalism by Singapore-based health care players, and the Singapore Tourism Board, which markets Singapore as a healthcare destination to inbound international patients and develops associated people-oriented services. (www.singaporemedicine.com)

###



Contact Information Felicia Tan

Singapore Tourism Board - Singapore Medicine

http://www.singaporemedicine.com/

+65 6831-3505



Monday, March 2, 2009

New Vertebral Biopsy Needle Features Exclusive Cutting Cannula

New Vertebral Biopsy Needle Features Exclusive Cutting Cannula

The new product: Serratus™ Vertebral Biopsy Needle is a specialty biopsy needle used to capture a quality vertebral core sample. This new product features an exclusive cutting cannula.

Attleboro, MA (PRWEB) March 2, 2009 -- NeedleTech Products, Inc. has introduced its new Serratus™ Vertebral Biopsy Needle, a specialty biopsy needle used to capture a quality vertebral core sample.

Designed to be used in conjunction with the company's 11- & 13-gauge Bonus™ Vertebral Access Needle, the ergonomically-engineered Serratus™ Vertebral Biopsy Needle features radiolucent handles and an exclusive serratus™ cutting cannula to capture a reliable bone biopsy.

The FDA has reviewed the company's pre-market notification submission (510K) and ruled the device Class 1 exempt. The Serratus™ Vertebral Biopsy Needle is available for immediate release in bulk or packaged and sterile.

More information is available at: http://www.needletech.com/html/serratus_vertebral_biopsy_need.html

# # #



Contact Information Russ Small

NeedleTech Products, Inc.

http://www.needletech.com

508-431-4000



Sunday, March 1, 2009

Ziosoft Names Bart Hendriks as Managing Director of New International Office

Ziosoft Names Bart Hendriks as Managing Director of New International Office

Mr. Hendriks will have responsibility for Europe, Middle East and Africa operations

Redwood City, CA (PRWEB) March 1, 2009 -- Ziosoft, http://www.ziosoftinc.com a leader in advanced visualization and analysis software for medical imaging today announced the appointment of Bart Hendriks as managing director for Europe, Middle East and Africa for Ziosoft International, a new office based in Brussels, Belgium. In his new position, Bart Hendriks will be responsible for Ziosoft's business strategy, business development and sales for the company's expansion into new markets in Europe, the Middle East and Africa.

Mr. Hendriks brings over 19 years of global sales, marketing, operations and financial expertise in the healthcare and IT software and hardware industries. He has a successful track record in leadership positions with both emerging and established companies. Mr. Hendriks' international experience includes Europe, the United States, China and India. "Bart Hendriks' in-depth experience and knowledge of the international healthcare industry will be instrumental as we expand into new markets" said Mark Koeniguer, Ziosoft chief operating officer. "Additionally, Mr. Hendriks' technical background and experience in advanced visualization and PACS environments will position Ziosoft well as our operations develop internationally."

Bart Hendriks will attend the European debut of the Ziosoft technology at the European Congress of Radiology at Ziosoft's booth, 586, Expo E, March 6-9 in Vienna, Austria.

About Ziosoft Inc.

Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA, Brussels, Belgium, and Tokyo, Japan. For more information, please visit http://www.ziosoftinc.com.

Ziosoft and Ziostation are registered trademarks of Ziosoft Inc.

###



Contact Information Betsy Davis

Ziosoft

http://www.ziosoftinc.com

650-413-1374